Publikationer pr. år
Publikationer pr. år
Publikationer pr. år
Klara Kvorning Ternov received her medical degree from the University of Copenhagen in 2015 and received her PhD degree in 2021, titled “Patient-reported outcomes and metabolic changes in men treated with enzalutamide or abiraterone acetate plus prednisone for metastatic castration-resistant prostate cancer”. Dr. Ternov is currently a resident at the Department of Urology, Copenhagen University Hospital - Herlev and Gentofte Hospital, Copenhagen, Denmark.
Metastatic castration-resistant prostate cancer; Abiraterone; Enzalutamide; Androgens; Patient-reported outcomes; Metabolic side-effects.
Serum androgens as predictive biomarkers in metastatic castration-resistent prostate cancer.
Long-term metabolic effects and patient-reported outcome of abiraterone and enzalutamide in metastatic castration-resistent prostate cancer.
None
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review
Publikation: Bidrag til tidsskrift › Review › peer review
Publikation: Konferencebidrag › Konferenceabstrakt til konference › Forskning › peer review
Publikation: Konferencebidrag › Konferenceabstrakt til konference › Forskning › peer review
Publikation: Bidrag til tidsskrift › Review › peer review